Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04934969 · ClinicalTrials.gov registry record · NA

The Adjunctive Use of Lavender and Peppermint Essential Oils

A NA study of Joint Diseases, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT04934969: Completed NA study of Joint Diseases, sponsored by University Hospitals Cleveland Medical Center.

NCT04934969 is a NA study of Joint Diseases that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 3 participants, below the 688-participant average among 9 other Joint Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04934969, a NA study of Joint Diseases, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

This study will use passive inhalation of lavender for discomfort, anxiety and peppermint for nausea following joint replacement and spine surgery

Primary Outcome

visual analog sale

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Adjunctive use of lavender and peppermint essential oils

Study Locations (1)

Ohio

  • University Hospitals of Cleveland - Cleveland

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-07-30
Est. Completion 2023-08-01
Phase NA

What the finished NCT04934969 record still lists

NCT04934969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 688-participant average among 9 other Joint Diseases trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Joint Diseases appearing as the primary indexed condition, and to 1 intervention - of which Adjunctive use of lavender and peppermint essential oils is the first listed.

NCT04934969 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04934969 about?

NCT04934969 is a clinical study titled "The Adjunctive Use of Lavender and Peppermint Essential Oils". This study will use passive inhalation of lavender for discomfort, anxiety and peppermint for nausea following joint replacement and spine surgery

What is the current status of trial NCT04934969?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2021-07-30. Estimated completion is 2023-08-01.

What conditions does trial NCT04934969 study?

This clinical trial studies the following conditions: Joint Diseases.

What interventions are being tested in trial NCT04934969?

The interventions under investigation include: Adjunctive use of lavender and peppermint essential oils (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04934969?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04934969 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Joint Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04934969's enrollment target sits among peer trials

3 10th of 9 the lowest of 9 other Joint Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Joint Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04934969, the US trial registry maintained by the National Library of Medicine. NCT04934969 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.